Venous thrombosis prophylaxis in haemophilics undergoing major orthopaedic surgery: A survey of haemophilia treatment centres

Haemophilia

Volumn 15, Issue 6, 2009, Pages 1337-1338

  Pradhan, S M ^a   Key, N S ^a   Boggio, L ^b   Pruthi, R ^c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

COMPRESSION GARMENT; HEALTH SURVEY; HEMOPHILIA; HIGH RISK PATIENT; HIP ARTHROPLASTY; HUMAN; KNEE ARTHROPLASTY; LETTER; MAJOR SURGERY; ORTHOPEDIC SURGERY; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK BENEFIT ANALYSIS; SUBSTITUTION THERAPY; THROMBOSIS PREVENTION; TREATMENT DURATION; UNITED STATES; VEIN THROMBOSIS;

HEALTH SURVEYS; HEMOPHILIA A; HUMANS; ORTHOPEDICS; VENOUS THROMBOSIS;

EID: 70449556112     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2009.02084.x     Document Type: Letter

References (5)

1. Geerts WH, Bergqvist D, Pineo GF. Prevention of venous thromboembolism: the Eighth ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2008, 133(6 Suppl.):381S-453S.
2. Dargaud Y, Meunier S, Negrier C. Haemophilia and thrombophilia: an unexpected association!. Haemophilia 2004, 10:319-26.
3. Koster T, Blann AD, Briët E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995, 345:152-5.
4. Pruthi RK, Heit JA, Green MM. Venous thromb oembolism after hip fracture surgery in a patient with haemophilia B and factor V Arg506Gln (factor V Leiden). Haemophilia 2000, 6:631-4.
5. Soucie JM, Ciangrini C, Janco RL. Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factors. Blood 2004, 103:2467-73.